| 摘要 |
The disclosure relates to a pharmaceutical preparation for inhalation, containing a compound of formula (I) as an exclusive active ingredient, wherein X represents an anion which is selected preferably from the groups comprising chloride, bromide, iodide, sulphate, phosphate, methane sulfonate, nitrate, meleate, acetate, citrate, fumarate, tartrate, oxalate, succinate, benzoate and p-toluolsulfonate, as a solvent ethanol or mixtures of ethanol and water, at least one pharmacologically compatible acid thereof, in addition to pharmacologically compatible auxiliary agents and/or complexing agents.
|
